Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer

(2011) J. W. Antoon et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer

(2011) Patricia A. Thompson et al.   PLoS One

Somatic mutations to CSMD1 in colorectal adenocarcinomas

(2010) Christopher Farrell et al.   CANCER BIOLOGY & THERAPY

PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer

(2010) J. Dupont Jensen et al.   CLINICAL CANCER RESEARCH

Breast cancer precursors revisited: molecular features and progression pathways

(2010) Maria A Lopez-Garcia et al.   HISTOPATHOLOGY

Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis

(2010) K. Kerlikowske et al.   JNCI-Journal of the National Cancer Institute

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer

(2010) Aslaug Aamodt Muggerud et al.   Molecular Oncology

The landscape of somatic copy-number alteration across human cancers

(2010) Rameen Beroukhim et al.   NATURE

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

(2010) S. A. Forbes et al.   NUCLEIC ACIDS RESEARCH

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

(2010) N Turner et al.   ONCOGENE

Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival

(2010) Virginia Espina et al.   PLoS One

High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays

(2009) Yuker Wang et al.   BMC Medical Genomics

Gene amplification in ductal carcinoma in situ of the breast

(2009) L. Burkhardt et al.   BREAST CANCER RESEARCH AND TREATMENT

Identification of Novel Gene Amplifications in Breast Cancer and Coexistence of Gene Amplification with an Activating Mutation of PIK3CA

(2009) M. Kadota et al.   CANCER RESEARCH

Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers

(2009) R. Natrajan et al.   CLINICAL CANCER RESEARCH

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival

(2009) C. Gjerdrum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fatty Acid Synthase Gene Is Up-regulated by Hypoxia via Activation of Akt and Sterol Regulatory Element Binding Protein-1

(2008) E. Furuta et al.   CANCER RESEARCH

Molecular Grading of Ductal Carcinoma In situ of the Breast

(2008) R. L. Balleine et al.   CLINICAL CANCER RESEARCH

Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast

(2008) A. Vincent-Salomon et al.   CLINICAL CANCER RESEARCH

High-resolution genomic and expression analyses of copy number alterations in breast tumors

(2008) Peter M. Haverty et al.   GENES CHROMOSOMES & CANCER

Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization

(2008) Yuxia Gao et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Peptides and Small Molecules Targeting the Plasminogen Activation System: Towards Prophylactic Anti-Metastasis Drugs for Breast Cancer

(2008) Joel Tyndall et al.   Recent Patents on Anti-Cancer Drug Discovery